Posthypoxic myoclonus is a rare and devastating complication of near-fatal cardiopulmonary arrest. Despite treatment with available anti-myoclonic agents, some patients may recover cognitively but remain completely disabled by severe myoclonus. We report a 16-year-old patient with severe treatment-refractory posthypoxic myoclonus, which improved markedly with administration of the drug sodium oxybate.
FruchtS.J., LeurgansS.E., HalletM., FahnS.The Unified Myoclonus Rating Scale. In: Myoclonus and paroxysmal dyskinesias. Advances in neurology. Vol. 89. Philadelphia: Lippincott Williams and Wilkins2002. p. 361–376.
2.
HoeschR.E., KoenigM.A., GeocadinR.G.Coma after global ischemic brain injury: pathophysiology and emerging therapies. Crit Care Clin2008; 24: 25–44.
3.
CavinessJ.N., brownP.Myoclonus: current concepts and recent advances. Lancet Neurol2004; 3: 598–607.
4.
VenkatesanA., FruchtS.Movement disorders after resuscitation from cardiac arrest. Neurol Clin2006; 24: 123–132.
5.
LanceJ.W., AdamsR.D.The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain1963; 86: 111–136.
